KYMR
Kymera Therapeutics Inc Earnings
$79.08
Earnings Summary
Revenue | $2.86Mn |
Net Profits | $-87.03Mn |
Net Profit Margins | -3043.01% |
Kymera Therapeutics Inc’s revenue fell -61.32% since last year same period to $2.86Mn in the Q4 2025. On a quarterly growth basis, Kymera Therapeutics Inc has generated 3.47% jump in its revenue since last 3-months.
Kymera Therapeutics Inc’s net profit fell -23.01% since last year same period to $-87.03Mn in the Q4 2025. On a quarterly growth basis, Kymera Therapeutics Inc has generated -5.91% fall in its net profits since last 3-months.
Kymera Therapeutics Inc’s net profit margin fell -218.01% since last year same period to -3043.01% in the Q4 2025. On a quarterly growth basis, Kymera Therapeutics Inc has generated -2.35% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.82 |
EPS Estimate Current Year | -0.82 |
Kymera Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.82 - a -3.67% fall from last quarter’s estimates.
Kymera Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.82.
Key Ratios
Earning Per Share (EPS) | 0 |
Kymera Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Kymera Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-04-30 | -0.82 | 0 | 100% |
